Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Vector Database


Welcome to Vector Database!

Vector database is a digital-only collection of vector backbone information compiled by Addgene from third party sources.

This vector is NOT available from Addgene and the database is no longer actively maintained.

This vector is not available from Addgene.

Plasmid: pGEX-5G/LIC

Information

Source/Vendor
ATCC
Plasmid Type
Unspecified
Cloning Method
Unknown
Size
4968
Notes
The order of the major features in this plasmid is:pMB1 ori - lacIq - lacZ' - tac - GST/SalI/SacII/thrombin cleavage site/BamHI - ampR. Vector is covered by a U.S. patent application and is distributed only for non-commercial use. (personal communication) Ligation-independent expression vector for constructing fusion proteins with a carrier polypeptide (glutathione S-transferase) which allows single-step affinity purification. The carrier protein can be removed by thrombin proteolysis. Preparation of the vector for cloning includes linearization with SacII, gel purification of the linearized vector, and treatment with T4 DNA polymerase in the presence of dATP. Target sequences for cloning are prepared by PCR and do not require restriction enzyme digestion. Design of PCR primers permits cloning in any reading frame. The forward primer should contain 15 nt complementary to nt 5' to the SacII site of the vector [(5'-3')(GGCCTGGTTCCGCGG)] followed by 12-15 nt corresponding to the target sequence (nt encoding the N-terminal 4-5 aa of the protein). The reverse primer should contain 14 nt complementary to nt 3' to the SacII site of the vector [(5'-3') (CTGCGCCTCGCTCC)] followed by 12 nt complementary to the 3' end of the target sequence. Annealing the vector and amplification product forms a gapped duplex molecule that can be used directly to transform bacteria without ligation. Both primers should contain a dAMP residue near the sequence complementary to the vector to terminate the exonucleolytic activity of subsequent T4 DNA polymerase treatment. Restriction digests of the clone give the following sizes (kb): SacII--5.1; PstI--5.1; SalI--5.1; PstI/BamHI--4.0, 0.98. (ATCC staff) Medium is 1227 LB plus ampicillin. Hosts: E.coli HB101, E.coli, E.coli DH5alpha. (Information source: VectorDB ( http://seq.yeastgenome.org/vectordb ).)
Catalog Number
77274
GenBank
M97937
Stable
Unspecified
Constitutive
Unspecified
Viral/Non-Viral
Unspecified

Sequence